About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Diagnostic Evaluation of the Tear Film | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00761917

Diagnostic Evaluation of the Tear Film

The objectives of this study are to assess for a difference between normal and dry eye subjects in tear film quality using a diagnostic interferometry device and to determine whether there are associa...

Lead sponsor: TearScience, Inc.•8 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

TearScience, Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Adults 18 year of age or older
•Willing and able to comply with study exam procedure

Exclusion Criteria

•Eyelid abnormality or ocular surface condition affecting ability to visualize tear film
•Women who are pregnant or nursing
•Any of the following conditions within specified timeframe prior to study participation:
•1. Instillation of eye drops
•2. Contact lens wear
•3. Use of oil-based facial cosmetics
•4. Swimming in chlorinated pool
•5. Eye examination procedures that may affect the tear film
•6. Participation in another ophthalmic clinical trial

Related studies

Clinical Applications of Advanced Ophthalmic Imaging

NCT03135327 · Multiple Sclerosis, Dry Eye Syndromes, and more

Assessment of TFT by OCT in Healthy Subjects and Subjects With DES

NCT02585414 · Dry Eye Syndromes

Difference of Tear Ferning Between Women with and Without Menopausal.

NCT06848829 · Dry Eye Syndromes

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

NCT06220474 · Dry Eye Syndromes, Meibomian Gland Dysfunction

RECRUITINGPhase 3

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

NCT06291194 · Dry Eye Syndromes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 31, 2015Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment229

Start dateJun 2008

Last updatedMar 31, 2015

Condition

Dry Eye Syndromes

Locations shown

Fayetteville, Arkansas

Morrow, Georgia

Oak Lawn, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 31, 2015Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions